First patient included in the CRUZ-SENIOR STUDY.Read more
Your publications are your success
We have only done our job well if you are successful.
Trust in data
Your data is ready. It has been checked, cleaned up and is now in a standardised format. We evaluate your data together with you. You ask the questions and we provide the analysis.
You can rely on the quality of your data and your results.
Publish and present
We work together with you on your presentations and publications. You can rely on us in review processes too. We are experts in the field and we specialise in cardiovascular diseases. We are able to work closely with you to provide fast responses, check everything one last time and answer any remaining questions.
We’ll also work late into the night to do this when necessary.
Your idea - your success
We congratulate you and celebrate with you. And we are already looking forward to your next idea.
Data Management Plans
Fully automatic edit checks
Law on the Reorganisation of the Pharmaceutical Market (AMNOG) reports
Data Validation Plans
Data Export Plans
21 CFR Part 11
Another important milestone has been achieved, allowing the Institute for Myocardial Infarction Research to generate new data to understand the efficacy and safety of cangrelor in high-risk patients.Read more
Day-to-day research results on the COVID-19 situation in hospitals, based on our own COVID-19 registry.Read more